Vital chemotherapy drugs used around the world have failed quality tests, putting cancer patients in more than 100 countries ...

$38,398 for a single shot of a very old cancer drug — and one "no-brainer" alternative By Arthur Allen October 26, 2022 / 5:00 AM EDT / Kaiser Health News ...

Patients with ovarian cancer are facing the worst outlook, Dr. Rao said, because of how common the disease is and how central the platinum drugs have been in tackling it for decades.

Since Bray's daughter rang the cancer-free bell in February 2021, she has continued the fight to end drug shortages for pediatric cancers through her nonprofit, Angels for Change.

The recent, abrupt shortage of critical cancer drugs highlights a broken business model in generic drugs that leaves patients in the U.S. and all over the world more vulnerable to similar shortages.

DRUG SHORTAGES IN CANCER, ASTHMA, TRANSPLANT, BACTERIAL INFECTION TREATMENTS. An NCCN survey of 27 U.S. cancer centers shows 93% have reported a shortage of Carboplatin, and 70% reported a ...

New Drugs for Cancer, Rare Disease Can Now Cost More Than $20,000 a Month. Trend follows rising pressure on companies to rein in repeat or annual price hikes for older drugs. By .

The drugs included in the price reductions treat a range of conditions, including cancer, diabetes and heart disease. The U.S. Department of Health and Human Services projects $1.5 billion savings ...

Study reveals new opportunities to develop cancer treatments Date: June 24, 2024 Source: Baylor College of Medicine Summary: Researchers uncovered new potential therapeutic targets for cancer and ...

So, Who Benefits From New Cancer Drugs? By Dennis Thompson HealthDay Reporter THURSDAY, Jan. 16, 2025 (HealthDay News) -- Cutting-edge targeted therapies are pushing back the line between life and ...

The 10 cancer clinicians KFF Health News interviewed for this story said that, given current shortages, they prioritize patients who can be cured over later-stage patients, in whom the drugs ...

After several rounds of treatment for a rare eye cancer — weekly drug infusions that could cost nearly $50,000 each — Paul Davis learned Medicare had abruptly stopped paying the bills. That ...